Home/Orega Biotech/Nathalie Bonnefoy
NB

Nathalie Bonnefoy

Founder & CSO

Orega Biotech

Roles

Founder & CSOatOrega Biotech
Cofounder & Scientific AdvisoratVentuno Biotech

Therapeutic Areas

Orega Biotech Pipeline

DrugIndicationPhase
IPH5201 (anti-CD39 mAb)Non-Small Cell Lung Cancer (NSCLC)Phase 2
Undisclosed Antibody ProgramUndisclosedPre-clinical